The CTN+ | Le Réseau+
@cihr_ctn
CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research | Réseau pancanadien pour des essais cliniques sur le VIH et autres ITSS
ID: 141302716
https://www.hivnet.ubc.ca/ 07-05-2010 18:33:09
11,11K Tweet
2,2K Followers
700 Following
Preliminary results for the #CTN313 study evaluating daily oral doxycycline for the prevention of syphilis in men living with HIV who have sex with men will be presented at #AIDS2024 (IAC - the International AIDS Conference). Troy Grennan MD MSc FRCPC, who led the study, discussed the clinical trial with the The New York Times.
“There was a 92% reduction in chlamydia, a 79% reduction in syphilis, and a 68% reduction in gonorrhea.” Troy Grennan MD MSc FRCPC (BC Centre for Disease Control) discusses his doxycycline as STI prevention research with HIV.gov, citing results from DaDHS (#CTN313) as well as sharing more about DISCO (#CTN329).
Why are syphilis cases in Canada on the rise? Centre universitaire de santé McGill's and The CTN+ | Le Réseau+'s Dr. Marina Klein joined Robyn Flynn to discuss: iheart.com/podcast/962-el…
New e-learning module alert! 🚨Developed in partnership with HIV Legal Network, “HIV Criminalization & Privacy Rights” is designed for service providers to understand legal rights and duties related to #HIV disclosure and privacy in #Canada. #HIVcriminalization catie.ca/resource/hiv-c…
⭐: Amanda Yonkman, Dr. Elizabeth King, Simon Fraser University SFU Health Sciences 📝: Comorbidity diagnoses and risk scores in women with and without HIV 🔗: ow.ly/iMuM50SYvI0
👏 Well done! 👏 Troy Grennan MD MSc FRCPC's research on doxycycline pre-exposure prophylaxis showing reductions of 79% in syphilis, 92% in chlamydia and 68% in gonorrhea in gbMSM was highlighted at #AIDS2024. Learn more about the DISCO trial (#CTN329) here: hivnet.ubc.ca/study/ctn-329-…
Congratulations to CTN+ Investigator (+ former CTN postdoc!) Dr. Ali Jenabian on his election to RSC // SRC’s College of New Scholars, Artists & Scientists! Dr. Jenabian is a professor in Immunology & Virology UQAM | Université du Québec à Montréal. More about the 2024 cohort: rsc-src.ca/sites/default/…
Félicitations à Dr Ali Jenabian, chercheur du CTN+ (et ancien postdoc du CTN !), pour sa élection au Collège de nouveaux chercheurs et créateurs en arts et en science de la RSC // SRC ! Le Dr. Jenabian est professeur d'immunologie et de virologie à UQAM | Université du Québec à Montréal. actualites.uqam.ca/2024/mohammad-…